CompletedNot Applicable

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

United States55 participantsStarted 2023-06-06

Plain-language summary

To evaluate the effectiveness, feasibility, acceptability, and appropriateness of an ototoxicity screening protocol among head and neck (H\&N) cancer patients followed in survivorship clinic that received cisplatin-based chemoradiation therapy (CRT).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult (≥ 18 years old) * H\&N cancer patients will be eligible for inclusion if they have previously undergone cisplatin-based CRT or radiotherapy, including proton therapy, intensity-modulated radiation therapy, and adaptive radiotherapy-surgery with curative intent (i.e., definitive, neoadjuvant, or adjuvant) or definitive surgery with neoadjuvant or adjuvant radiation. Exclusion Criteria: * Patient has been evaluated by an audiologist within the past 12 months * Use of a hearing aid * Received a cochlear implant * Cannot complete simple forms in English

What they're measuring

Rate of participants who complete audiologic follow-up

Timeframe: Through completion of follow-up (estimated to be 6 months)

Trial details

NCT IDNCT05789316

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-21

View on ClinicalTrials.gov More Head and Neck Cancer Survivors trials